SZLSF
STAGEZERO LIFE SCIENCES by Stagezero Life Sciences Ltd. (SZLSF)
$02
About STAGEZERO LIFE SCIENCES by Stagezero Life Sciences Ltd. (SZLSF)
StageZero Life Sciences Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for detection of diseases and for personalized health management, with a focus on cancer-related indications. Its products includes Sentinel Principle, and ColonSentry. The company was founded by Choong-Chin Liew and K. Wayne Marshall on February 20, 1997 and is headquartered in Richmond Hill, Canada.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$1.00
52 Week Low
$0.00
Market cap
2.3M
Dividend yield
0.00%
Volume
--
Avg. volume
303
P/E ratio
-.16
STAGEZERO LIFE SCIENCES by Stagezero Life Sciences Ltd. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$1.00
52 Week Low
$0.00
Market cap
2.3M
Dividend yield
0.00%
Volume
--
Avg. volume
303
P/E ratio
-.16